BackBiofrontera AG Overview

Biofrontera AG Receivables

Track Biofrontera AG's receivables ($2.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.81M
37.52% YoYΔ $768000.00 vs prior year quarter

Peer average

Loading

Biofrontera AG Receivables History

Loading

Biofrontera AG vs. peers: Receivables Comparison

Loading

Biofrontera AG Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Biofrontera AG (BFRA) FAQ

As of the most recent data (September 2021), BFRA shows a receivables of $2.8M. That compares with $2M in the prior-year period — up 37.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BFRA's receivables is now $2.8M (was $2M) — a 37.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biofrontera AG is outperforming or lagging.

Tracking BFRA's receivables over time shows whether Biofrontera AG is scaling, shrinking, or reshaping that part of the business. The current reading is $2.8M That compares with $2M in the prior-year period — up 37.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Biofrontera AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $2.8M) with ownership activity and broader fundamentals.

Biofrontera AG's receivables is $2.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.